全文获取类型
收费全文 | 4521篇 |
免费 | 286篇 |
国内免费 | 100篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 178篇 |
妇产科学 | 145篇 |
基础医学 | 588篇 |
口腔科学 | 153篇 |
临床医学 | 515篇 |
内科学 | 865篇 |
皮肤病学 | 50篇 |
神经病学 | 341篇 |
特种医学 | 64篇 |
外科学 | 457篇 |
综合类 | 187篇 |
预防医学 | 376篇 |
眼科学 | 78篇 |
药学 | 401篇 |
7篇 | |
中国医学 | 129篇 |
肿瘤学 | 332篇 |
出版年
2024年 | 8篇 |
2023年 | 38篇 |
2022年 | 102篇 |
2021年 | 117篇 |
2020年 | 85篇 |
2019年 | 106篇 |
2018年 | 113篇 |
2017年 | 103篇 |
2016年 | 110篇 |
2015年 | 141篇 |
2014年 | 171篇 |
2013年 | 210篇 |
2012年 | 301篇 |
2011年 | 318篇 |
2010年 | 185篇 |
2009年 | 168篇 |
2008年 | 268篇 |
2007年 | 289篇 |
2006年 | 265篇 |
2005年 | 259篇 |
2004年 | 213篇 |
2003年 | 221篇 |
2002年 | 188篇 |
2001年 | 53篇 |
2000年 | 75篇 |
1999年 | 63篇 |
1998年 | 50篇 |
1997年 | 59篇 |
1996年 | 57篇 |
1995年 | 49篇 |
1994年 | 41篇 |
1993年 | 36篇 |
1992年 | 47篇 |
1991年 | 47篇 |
1990年 | 41篇 |
1989年 | 42篇 |
1988年 | 35篇 |
1987年 | 26篇 |
1986年 | 20篇 |
1985年 | 12篇 |
1984年 | 18篇 |
1983年 | 21篇 |
1982年 | 13篇 |
1981年 | 18篇 |
1980年 | 11篇 |
1979年 | 16篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1974年 | 7篇 |
1972年 | 10篇 |
排序方式: 共有4907条查询结果,搜索用时 15 毫秒
21.
22.
Olle Ringdén Marie Schaffer Katarina Le Blanc Ulla Persson Dan Hauzenberger Mohammad R Abedi Olle Olerup Per Ljungman Mats Remberger 《Biology of blood and marrow transplantation》2004,10(2):128-134
The aim of this study was to identify significant prognostic factors by using unrelated genomically HLA-A, -B and -DRB1-identical donors. Such data could help to choose the best donor. We studied 136 consecutive patients with hematologic malignancies and a median age of 32 years (range, 0-55 years) who received hematopoietic stem cell transplantation. Bone marrow grafts were given to 83 and peripheral blood stem cells to 53 patients. The cumulative incidence of grade II to IV acute graft-versus-host disease (GVHD) was 30% and of chronic GVHD was 54%. At 5 years, the overall transplant-related mortality (TRM) was 34%, and patient survival was 50%. In Cox multivariate analysis, 32 potential risk factors were analyzed. Monoclonal antibody OKT-3 during conditioning was correlated with grade II to IV acute GVHD, chronic GVHD, and TRM. HLA-DP mismatch was associated with poor TRM and poor survival. Cytomegalovirus-seropositive patients with a seronegative donor had a decreased leukemia-free survival. Five-year TRM was 14% with no risk factor, 38% with 1 risk factor, and 87% with 2 risk factors. The 5-year survival was 72%, 48%, and 30% with 0, 1, and 2 risk factors, respectively. We concluded that unrelated hematopoietic stem cell transplantation may be improved if an optimal donor and immunosuppression are chosen. 相似文献
23.
Travis BR Marzec UM Leo HL Momin T Sanders C Hanson SR Yoganathan AP 《Annals of biomedical engineering》2001,29(8):657-664
The clinical histories of the Medtronic Parallel (MP) and St. Jude Medical (SJM) Standard valves suggest pivot geometry influences the thrombogenic characteristics of bileaflet prostheses. This work studied the effects of various pivot geometries on markers of platelet damage in a controlled, in vitro apparatus. The Medtronic Parallel valve, two St. Jude Medical valves, and two demonstration prostheses were used to study the effects of bileaflet pivot design, gap width, and size on platelet secretion and anionic phospholipid expression during leakage flow. A centrifugal pump was used to drive blood through a circuit containing a bileaflet prosthesis. Samples were taken at set time intervals after the start of the pump. These samples were analyzed by cell counting, flow cytometry, and enzyme-linked immunosorbant assay. No significant differences were observed in platelet secretion or anionic phospholipid expression between experiments with the SJM 27 Standard regular leaker, the SJM 20 regular leaker, and the MP 27 valves. Significant differences in platelet secretion and anionic phospholipid expression were observed between a SJM 27 Standard regular leaker and a SJM 27 high leaker valve. These studies suggest that leakage gap width within bileaflet valve pivots has a significant effect on platelet damage initiated by leakage flow. © 2001 Biomedical Engineering Society.
PAC01: 8719Uv, 8719Tt, 8380Lz, 8768+z 相似文献
24.
Liefeldt L Plentz A Klempa B Kershaw O Endres AS Raab U Neumayer HH Meisel H Modrow S 《Journal of medical virology》2005,75(1):161-169
Organ transplant recipients infected with parvovirus B19 frequently develop persistent viremia associated with chronic anemia and pure red cell aplasia. In this study, a male renal transplant recipient who had been infected with parvovirus B19/genotype 2 after renal transplantation at the age of 34 years is described. The patient was repeatedly treated with high dose intravenous immunoglobulin (IVIG) that resulted in the resolvement of symptoms but not in virus eradication. During an observation period of 33 months after transplantation three phases associated with high parvovirus B19 viremia were observed. Both the first and the second viremic phases were combined with severe anemia. Parvovirus B19 specific IgM-antibodies were initially detected at the beginning of the second phase in continually rising concentrations. Initially eradication of the virus by immunoglobulin therapy was reported after the first viremic phase [Liefeldt et al. (2002): Nephrol Dial Transplant 17:1840-1842]. Retrospectively this statement has to be corrected. It was based on the use of a qualitative PCR assay specific for parvovirus B19 genotype 1 associated with reduced sensitivity for detection of genotype 2. After sequence analysis of the viral DNA and adjustment of a real-time PCR assay (TaqMan) for quantitative detection of all three B19 virus genotypes analysis of consecutive serum samples allowed the demonstration of long lasting phases with reduced viral loads following IVIG-treatment. These results demonstrate that IVIG treatment of parvovirus B19-triggered anemia in transplant recipients offers an opportunity to resolve symptoms, but does not guarantee eradication of the virus. Since reactivation of parvovirus B19 infection can result in high virus load associated with the recurrence of symptoms repeated screening for viral DNA is recommended using the TaqMan system established for quantitative detection of all three genotypes of parvovirus B19. 相似文献
25.
26.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - In den vergangenen 3 Jahrzehnten nahm die Qualitätsentwicklung in der Primärprävention und... 相似文献
27.
目的观察长链非编码RNA Linc00472(LncRNA Linc00472)靶向调控微小RNA-381(miR-381)对骨肉瘤细胞增殖、凋亡、迁移、侵袭的影响。方法收集2017年3月至2018年5月郑州大学第一附属医院收治的骨肉瘤患者29例为研究对象,实时荧光定量聚合酶链反应(RT-qPCR)检测骨肉瘤组织和瘤旁组织中Linc00472的表达。将骨肉瘤U2OS细胞分为pcDNA3.1组、pcDNA3.1-Linc00472组、pcDNA3.1-Linc00472+miR-NC组、pcDNA3.1-Linc00472+miR-381组。甲基噻唑基四唑(MTT)检测细胞增殖;流式细胞术检测细胞凋亡;Transwell实验检测细胞迁移及侵袭。双荧光素酶报告实验鉴定Linc00472与miR-381的靶向关系。两组间比较采用独立样本t检验,多组间比较采用单因素方差分析。结果Linc00472在骨肉瘤组织中的表达水平低于瘤旁组织(0.31±0.03比1.03±0.10,t=37.138,P<0.05),差异有统计学意义;与pcDNA3.1组比较,pcDNA3.1-Linc00472组细胞存活率[(100.29±10.12)%比(53.29±5.44)%]低于pcDNA3.1组(t=12.272,P<0.05),差异有统计学意义,迁移细胞数[(266.00±23.61)个比(124.00±12.01)个]与侵袭细胞数[(131.00±13.06)个比(62.00±6.24)个]少于pcDNA3.1组(t=16.082,P<0.05;t=14.301,P<0.05),差异有统计学意义,而细胞凋亡率[(8.58±0.91)%比(26.61±2.64)%]高于pcDNA3.1组(t=19.370,P<0.05),差异有统计学意义;miR-381过表达可抑制野生型载体WT-Linc00472细胞的荧光素酶活性(t=19.827,P<0.05),差异有统计学意义;与pcDNA3.1-Linc00472+miR-NC组比较,pcDNA3.1-Linc00472+miR-381组可增强细胞增殖[(53.17±5.33)%比(85.26±8.62)%]、迁移[(122.00±12.31)个比(223.00±22.18)个]及侵袭[(64.00±6.36)个比(104.00±10.20)个]能力高于pcDNA3.1-Linc00472+miR-NC组(t=9.499,P<0.05;t=11.945,P<0.05;t=9.983,P<0.05),细胞凋亡率[(26.11±2.62)%比(13.11±1.34)%]低于pcDNA3.1-Linc00472+miR-NC组(t=13.253,P<0.05),差异有统计学意义。结论LncRNA Linc00472通过靶向调控miR-381可抑制骨肉瘤细胞增殖、迁移及侵袭并诱导细胞凋亡。 相似文献
28.
Kou H.-W. Yeh C.-N. Tsai C.-Y. Hsu J.-T. Wang S.-Y. Lee C.-W. Yu M.-C. Hwang T.-L. 《Hernia》2021,25(5):1317-1324
Hernia - Occult inguinal hernias (IH) predispose peritoneal dialysis (PD) patients to the symptomatic IH formation after starting PD, which may cause complications. We conducted a retrospective... 相似文献
29.
High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma 总被引:2,自引:0,他引:2
Puhakka A Kinnula V Näpänkangas U Säily M Koistinen P Pääkkö P Soini Y 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2003,111(12):1137-1146
Immunohistochemical expression of neuronal (n), endothelial (e), and inducible (i) NOS and their association with the type, grade, apoptotic index, proliferation of tumors and the survival of patients were investigated in 89 biopsies of non-small cell lung carcinoma (NSCLC). In tumor cells, expression of iNOS was detected in 35/89 (40%) cases, while 79/89 (89%) and 72/89 (81%) cases showed weak to intense positivity for eNOS and nNOS, respectively. Strong eNOS staining was seen significantly more often in adenocarcinomas than in squamous cells carcinomas (p=0.016), and iNOS immunoreactivity was seen more often in grade I-II tumors than in grade III tumors (p=0.024). There was no significant difference between the low and high apoptotic indexes or between the low and high proliferation rates of tumors in any instance of NOS staining. The patients with tumors showing high nNOS expression tended to have better survival than the others (p=0.06, log-rank; p=0.04, Bresow; p=0.048, Tarone-Ware). Similarly, the patients with tumors showing high expression of iNOS, eNOS and nNOS, as determined by a combined sum index, had a better survival than those with a low sum index for these enzymes (p<0.05). The results show intense expression of eNOS and nNOS, and moderate expression of iNOS in tumor cells of non-small cell carcinoma. Intense NOSs expression seems to be a favorable prognostic sign in non-small cell lung carcinoma. 相似文献
30.